Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 7/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.70 |
| ▸ | MAPT | P10636 | 7/20 | 0.69 |
| ▸ | LMNA | P02545 | 3/20 | 0.69 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.69 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.69 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.69 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.69 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.69 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.69 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.69 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | PLIN5 | Q00G26 | 1/20 | 0.55 |
| ▸ | ABHD5 | Q8WTS1 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14811753 | 0.95 | MEN1 (0.64) | MEN1KMT2AMAPTLMNANPSR1 | |
| SCHEMBL8182437 | 0.95 | MEN1 (0.64) | MEN1KMT2AMAPTLMNANPSR1 | |
| Malonic Acid SCHEMBL6825036 | 0.93 | MEN1 (0.65) | MEN1KMT2AMAPTLMNANPSR1 | |
| SCHEMBL30553780 | 0.92 | KMT2A (0.66) | MEN1KMT2AMAPTLMNANPSR1 | |
| SCHEMBL10851464 | 0.92 | KMT2A (0.66) | MEN1KMT2AMAPTLMNANPSR1 | |
| SCHEMBL134782 | 0.92 | MEN1 (0.64) | MEN1KMT2AMAPTLMNANPSR1 | |
| SCHEMBL10851473 | 0.92 | KMT2A (0.66) | MEN1KMT2AMAPTLMNANPSR1 | |
| SCHEMBL1068265 | 0.89 | MEN1 (0.85) | MEN1KMT2AMAPTLMNANPSR1 | |
| SCHEMBL11776370 | 0.88 | NR1H4 (0.55) | MEN1KMT2AMAPTLMNANPSR1 | |
| SCHEMBL11729192 | 0.88 | MEN1 (0.55) | MEN1KMT2AMAPTLMNANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 332 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119841982-A | Catalyst for olefin polymerization and olefin polymerization method | 中国石油化工股份有限公司 | 2025-04-18 | — | — | CN | claimed |
| CN-119841979-A | Catalyst for olefin polymerization and olefin polymerization method | 中国石油化工股份有限公司 | 2025-04-18 | — | — | CN | claimed |
| CN-119841980-A | Catalyst for olefin polymerization and olefin polymerization method | 中国石油化工股份有限公司 | 2025-04-18 | — | — | CN | claimed |
| US-10723998-B2 | Application of ethyl p-methoxycinnamate and derivatives thereof in maintaining self-renewal and pluripotency of stem cells | NORTHEAST NORMAL UNIVERSITY (CN) | 2020-07-28 | — | — | US | claimed |
| CN-106543314-B | The application of catalyst containing ether ester and the catalyst and ether ester in olefin polymerization | 中国石油化工股份有限公司 | 2019-02-19 | — | — | CN | claimed |
| US-20180195039-A1 | APPLICATION OF ETHYL P-METHOXYCINNAMATE AND DERIVATIVES THEREOF IN MAINTAINING SELF-RENEWAL AND PLURIPOTENCY OF STEM CELLS | NORTHEAST NORMAL UNIVERSITY (CN) | 2018-07-12 | — | — | US | claimed |
| EP-1082015-B1 | STABILIZED ANTIMICROBIAL COMPOSITIONS CONTAINING HALOPROPYNYL COMPOUNDS | TROY TECHNOLOGY CORP INC (US) | 2007-06-27 | — | — | EP | claimed |
| EP-1082015-A4 | STABILIZED ANTIMICROBIAL COMPOSITIONS CONTAINING HALOPROPYNYL COMPOUNDS | TROY TECHNOLOGY CORP INC (US) | 2002-03-20 | — | — | EP | claimed |
| EP-1082015-A1 | STABILIZED ANTIMICROBIAL COMPOSITIONS CONTAINING HALOPROPYNYL COMPOUNDS | Troy Technology Corporation, Inc. (US) | 2001-03-14 | — | — | EP | claimed |
| WO-1999059410-A1 | STABILIZED ANTIMICROBIAL COMPOSITIONS CONTAINING HALOPROPYNYL COMPOUNDS | TROY TECHNOLOGY CORPORATION, INC. (US) | 1999-11-25 | — | — | WO | claimed |
| US-5938825-A | ALSO CONTAINING SELECTED ULTRAVIOLET RADIATION ABSORBER | TROY TECHNOLOGY CORPORATION INC. (US) | 1999-08-17 | — | — | US | claimed |
| EP-0848947-B1 | Compositions containing a derivative of dibenzoylmethane, a derivative of 1,3,4-triazine and an dialkly benyalmalonate | OREAL (FR) | 1999-08-11 | — | — | EP | claimed |
| US-5882634-A | COSMETICS AND SKINS | SOCIETE L'OREAL S.A. (FR) | 1999-03-16 | — | — | US | claimed |
| US-5670140-A | SKIN PROTECTION FOR COSMETICS FOR RADIATION RESISTANCE | L'OREAL (FR) | 1997-09-23 | — | — | US | claimed |
| US-5624663-A | Photostable cosmetic filter composition cotaining a UV-A filter and a substituted dialkylbenzalmalonate, the use of substituted dialkylbenzalmalonates in cosmetics as broad-band solar filters and novel substituted dialkyl malonates | L'OREAL (FR) | 1997-04-29 | — | — | US | claimed |
| JP-10175838-A | — | — | None | — | — | JP | disclosed |
| US-12617955-B2 | Additive production process with a thermoplastic radically cross-linkable construction material | STRATASYS, INC. (US) | 2026-05-05 | — | — | US | disclosed |
| US-3959220-A | Polymer additives comprising transition metal complexes with trivalent phosphorous compounds | CINCINNATI MILACRON CHEMICALS, INC. (US) | 1976-05-25 | — | — | US | disclosed |
| US-3958003-A | HETEROCYCLIC COMPOUND, ANALGESICS CENTRAL NERVOUS SYSTEM DEPRESSANT | SANDOZ LTD. (CH) | 1976-05-18 | — | — | US | disclosed |
| US-3943098-A | 1-Aza-4-thiacyclohexane-4,4-dioxide derivatives and their use as agents protecting against light rays | CIBA-GEIGY CORPORATION (US) | 1976-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180195039-A1 | APPLICATION OF ETHYL P-METHOXYCINNAMATE AND DERIVATIVES THEREOF IN MAINTAINING SELF-RENEWAL AND PLURIPOTENCY OF STEM CELLS | XPA, MEP1A, EED | MEN1 809/4885KMT2A 1689/4885MAPT 4688/4885 |
| US-12617955-B2 | Additive production process with a thermoplastic radically cross-linkable construction material | UBE2G2, MTCL3, RAD51 | MEN1 2540/4885KMT2A 2613/4885MAPT 253/4885 |
| US-10723998-B2 | Application of ethyl p-methoxycinnamate and derivatives thereof in maintaining self-renewal and pluripotency of stem cells | XPA, MEP1A, EED | MEN1 809/4885KMT2A 1689/4885MAPT 4688/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.